Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1987 Feb;57(2):125–132. doi: 10.1136/hrt.57.2.125

Factors influencing survival and mode of death in severe chronic ischaemic cardiac failure.

D R Glover, W A Littler
PMCID: PMC1277092  PMID: 3814447

Abstract

An evaluation of factors which may influence survival and mode of death was conducted over a three year period in a consecutive series of 50 patients with severe chronic ischaemic cardiac failure for more than three months. At the initial assessment all patients were already receiving intensive medical treatment. During follow up four patients successfully underwent cardiac surgery and medical treatment was modified in most patients, with four patients receiving antiarrhythmic drugs. Twenty six patients died: 17 suddenly within one hour of onset of symptoms and nine of progressive cardiac failure. The mortality by one year was 26% and by two years it was 62%. Comparison of those who survived with those who died within one year of follow up showed that a very low left ventricular ejection fraction, severe ventricular arrhythmias, the presence of gallop rhythm, and New York Heart Association class IV were the variables that predicted mortality. By two years left ventricular ejection fraction, ventricular arrhythmias, and pulmonary capillary wedge pressure were the variables that were significantly different in survivors and patients who died. No differences were found in any of the recorded variables between those who died suddenly and those who did not. Thus in patients with chronic ischaemic cardiac failure determination of the left ventricular ejection fraction and the severity of ventricular arrhythmia on the ambulatory electrocardiogram are the best ways to predict prognosis. The presence of gallop rhythm and New York Heart Association class IV status predict early death.

Full text

PDF
125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bruschke A. V., Proudfit W. L., Sones F. M., Jr Progress study of 590 consecutive nonsurgical cases of coronary disease followed 5-9 years. II. Ventriculographic and other correlations. Circulation. 1973 Jun;47(6):1154–1163. doi: 10.1161/01.cir.47.6.1154. [DOI] [PubMed] [Google Scholar]
  2. Burggraf G. W., Parker J. O. Prognosis in coronary artery disease. Angiographic, hemodynamic, and clinical factors. Circulation. 1975 Jan;51(1):146–156. doi: 10.1161/01.cir.51.1.146. [DOI] [PubMed] [Google Scholar]
  3. Capucci A., Frabetti L., Melandri G., Magnani B. Electrophysiologic properties of prenalterol. Int J Cardiol. 1983;2(3-4):391–400. doi: 10.1016/0167-5273(83)90011-6. [DOI] [PubMed] [Google Scholar]
  4. Chatterjee K., Parmley W. W. Vasodilator therapy for chronic heart failure. Annu Rev Pharmacol Toxicol. 1980;20:475–512. doi: 10.1146/annurev.pa.20.040180.002355. [DOI] [PubMed] [Google Scholar]
  5. Cleland J. G., Dargie H. J., Ball S. G., Gillen G., Hodsman G. P., Morton J. J., East B. W., Robertson I., Ford I., Robertson J. I. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J. 1985 Sep;54(3):305–312. doi: 10.1136/hrt.54.3.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cleland J. G., Dargie H. J., Hodsman G. P., Ball S. G., Robertson J. I., Morton J. J., East B. W., Robertson I., Murray G. D., Gillen G. Captopril in heart failure. A double blind controlled trial. Br Heart J. 1984 Nov;52(5):530–535. doi: 10.1136/hrt.52.5.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
  8. Cohn J. N., Franciosa J. A. Vasodilator therapy of cardiac failure: (first of two parts). N Engl J Med. 1977 Jul 7;297(1):27–31. doi: 10.1056/NEJM197707072970105. [DOI] [PubMed] [Google Scholar]
  9. Cohn J. N., Levine T. B., Olivari M. T., Garberg V., Lura D., Francis G. S., Simon A. B., Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984 Sep 27;311(13):819–823. doi: 10.1056/NEJM198409273111303. [DOI] [PubMed] [Google Scholar]
  10. Detre K., Peduzzi P., Murphy M., Hultgren H., Thomsen J., Oberman A., Takaro T. Effect of bypass surgery on survival in patients in low- and high-risk subgroups delineated by the use of simple clinical variables. Circulation. 1981 Jun;63(6):1329–1338. doi: 10.1161/01.cir.63.6.1329. [DOI] [PubMed] [Google Scholar]
  11. Dzau V. J., Colucci W. S., Williams G. H., Curfman G., Meggs L., Hollenberg N. K. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med. 1980 Jun 19;302(25):1373–1379. doi: 10.1056/NEJM198006193022501. [DOI] [PubMed] [Google Scholar]
  12. Follansbee W. P., Michelson E. L., Morganroth J. Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac death. Ann Intern Med. 1980 Jun;92(6):741–747. doi: 10.7326/0003-4819-92-6-741. [DOI] [PubMed] [Google Scholar]
  13. Franciosa J. A., Wilen M., Ziesche S., Cohn J. N. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1983 Mar 1;51(5):831–836. doi: 10.1016/s0002-9149(83)80141-6. [DOI] [PubMed] [Google Scholar]
  14. Furberg C. D., Yusuf S. Effect of vasodilators on survival in chronic congestive heart failure. Am J Cardiol. 1985 Apr 1;55(8):1110–1113. doi: 10.1016/0002-9149(85)90756-8. [DOI] [PubMed] [Google Scholar]
  15. Glover D. R., Wathen C. G., Murray R. G., Petch M. C., Muir A. L., Littler W. A. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo. Br Heart J. 1985 Feb;53(2):208–215. doi: 10.1136/hrt.53.2.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hillis W. S., Whiting B. Antiarrhythmic drugs. Br Med J (Clin Res Ed) 1983 Apr 23;286(6374):1332–1336. doi: 10.1136/bmj.286.6374.1332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Holmes J., Kubo S. H., Cody R. J., Kligfield P. Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. Am J Cardiol. 1985 Jan 1;55(1):146–151. doi: 10.1016/0002-9149(85)90317-0. [DOI] [PubMed] [Google Scholar]
  18. Kennedy J. W., Kaiser G. C., Fisher L. D., Fritz J. K., Myers W., Mudd J. G., Ryan T. J. Clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS). Circulation. 1981 Apr;63(4):793–802. doi: 10.1161/01.cir.63.4.793. [DOI] [PubMed] [Google Scholar]
  19. LeJemtel T. H., Keung E., Sonnenblick E. H., Ribner H. S., Matsumoto M., Davis R., Schwartz W., Alousi A. A., Davolos D. Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation. 1979 Jun;59(6):1098–1104. doi: 10.1161/01.cir.59.6.1098. [DOI] [PubMed] [Google Scholar]
  20. Lown B., Wolf M. Approaches to sudden death from coronary heart disease. Circulation. 1971 Jul;44(1):130–142. doi: 10.1161/01.cir.44.1.130. [DOI] [PubMed] [Google Scholar]
  21. Marcus F. I., Fontaine G. H., Frank R., Grosgogeat Y. Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone. Am Heart J. 1981 Apr;101(4):480–493. doi: 10.1016/0002-8703(81)90140-x. [DOI] [PubMed] [Google Scholar]
  22. Massie B., Ports T., Chatterjee K., Parmley W., Ostland J., O'Young J., Haughom F. Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements. Circulation. 1981 Feb;63(2):269–278. doi: 10.1161/01.cir.63.2.269. [DOI] [PubMed] [Google Scholar]
  23. McKee P. A., Castelli W. P., McNamara P. M., Kannel W. B. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971 Dec 23;285(26):1441–1446. doi: 10.1056/NEJM197112232852601. [DOI] [PubMed] [Google Scholar]
  24. Mock M. B., Ringqvist I., Fisher L. D., Davis K. B., Chaitman B. R., Kouchoukos N. T., Kaiser G. C., Alderman E., Ryan T. J., Russell R. O., Jr Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation. 1982 Sep;66(3):562–568. doi: 10.1161/01.cir.66.3.562. [DOI] [PubMed] [Google Scholar]
  25. Packer M. Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation. 1985 Oct;72(4):681–685. doi: 10.1161/01.cir.72.4.681. [DOI] [PubMed] [Google Scholar]
  26. Petch M. C. Digoxin for heart failure in sinus rhythm. Thorax. 1979 Apr;34(2):147–149. doi: 10.1136/thx.34.2.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Poll D. S., Marchlinski F. E., Buxton A. E., Doherty J. U., Waxman H. L., Josephson M. E. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy. Circulation. 1984 Sep;70(3):451–456. doi: 10.1161/01.cir.70.3.451. [DOI] [PubMed] [Google Scholar]
  28. Selzer A. Digitalis in cardiac failure. Do benefits justify risks? Arch Intern Med. 1981 Jan;141(1):18–19. [PubMed] [Google Scholar]
  29. Sharpe D. N., Murphy J., Coxon R., Hannan S. F. Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study. Circulation. 1984 Aug;70(2):271–278. doi: 10.1161/01.cir.70.2.271. [DOI] [PubMed] [Google Scholar]
  30. Wilson J. R. How and when patients with severe heart failure die. Int J Cardiol. 1984 Aug;6(2):255–258. doi: 10.1016/0167-5273(84)90363-2. [DOI] [PubMed] [Google Scholar]
  31. Wilson J. R., Schwartz J. S., Sutton M. S., Ferraro N., Horowitz L. N., Reichek N., Josephson M. E. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol. 1983 Sep;2(3):403–410. doi: 10.1016/s0735-1097(83)80265-4. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES